menu
    • menu

    Company profile for Phaxiam Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    PHAXIAM is a biopharmaceutical company dedicated to the development of innovative treatments specifically designed for resistant bacterial infections, a significant contributor to serious infections. The company employs a pioneering approach centered around the utilization of phages, naturally occurring viruses that can target and kill bacteria. PHAXIAM is actively building a portfolio of phages that focus on three of the most...
    PHAXIAM is a biopharmaceutical company dedicated to the development of innovative treatments specifically designed for resistant bacterial infections, a significant contributor to serious infections. The company employs a pioneering approach centered around the utilization of phages, naturally occurring viruses that can target and kill bacteria. PHAXIAM is actively building a portfolio of phages that focus on three of the most resilient and perilous bacteria—Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Phaxiam TherapeuticsFrance Flag
    Country
    Country
    France
    Address
    Address
    60, avenue Rockefeller Bâtiment Bioserra 69008 Lyon
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://phaxiam.com/en/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/phaxiam/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    Global ChemShow

    Not Confirmed

    envelop Contact Supplier

    Global ChemShow

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Phaxiam Reports Voting Rights & Share Capital for Nov 2024
    Phaxiam Reports Voting Rights & Share Capital for Nov 2024

    05 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/05/2992592/0/en/PHAXIAM-Therapeutics-monthly-information-related-to-total-number-of-voting-rights-and-shares-composing-the-share-capital-November-29-2024.html

    GLOBENEWSWIRE
    05 Dec 2024
    Share Share
    Phaxiam Presents Strategy for Evolving Phage Therapy Development
    Phaxiam Presents Strategy for Evolving Phage Therapy Development

    27 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/27/2988208/0/en/PHAXIAM-Therapeutics-presents-an-ambitious-development-strategy-to-take-advantage-of-the-rapidly-evolving-Phages-therapy-area.html

    GLOBENEWSWIRE
    27 Nov 2024
    Share Share
    PHAXIAM Presents IVD Phagogram Test & Phage Susceptibility Tracking
    PHAXIAM Presents IVD Phagogram Test & Phage Susceptibility Tracking

    18 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/18/2983023/0/en/PHAXIAM-Presented-its-IVD-Phagogram-test-and-updated-phage-susceptibility-tracking-at-the-first-Phagogram-Day.html

    GLOBENEWSWIRE
    18 Nov 2024
    Share Share
    PHAXIAM Reports Third-Quarter 2024 Financial Information
    PHAXIAM Reports Third-Quarter 2024 Financial Information

    13 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/13/2980518/0/en/PHAXIAM-Reports-Third-Quarter-2024-Financial-Information.html

    GLOBENEWSWIRE
    13 Nov 2024
    Share Share
    Monthly Voting Rights & Share Capital Information as of Oct 31
    Monthly Voting Rights & Share Capital Information as of Oct 31

    08 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/08/2977784/0/en/Monthly-information-related-to-total-number-of-voting-rights-and-shares-composing-the-share-capital-October-31-2024.html

    GLOBENEWSWIRE
    08 Nov 2024
    Share Share
    PHAXIAM Therapeutics Receives FDA Clearance for Phase II Study
    PHAXIAM Therapeutics Receives FDA Clearance for Phase II Study

    04 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/04/2974299/0/en/PHAXIAM-Therapeutics-Receives-FDA-Clearance-to-Initiate-Phase-II-GLORIA-Study-in-the-U-S.html

    GLOBENEWSWIRE
    04 Nov 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search